FUDANZHANGJIANG Calls 28 May 2026 AGM; Seeks RMB300.00 Million A-Share Mandate and Board Re-election

Bulletin Express
Apr 29

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has convened its 2026 annual general meeting (AGM) for 1:30 p.m. on 28 May 2026 at No. 308 Cailun Road, Zhangjiang Hi-Tech Park, Shanghai. Key agenda items are as follows:

Special resolution • General mandate: The Board will request authority to issue, allot or deal in additional A-shares up to 20% of the current A-share capital. Aggregate proceeds are capped at RMB300.00 million and may not exceed 20% of net assets. The authorisation will remain valid until the earliest of (i) the 2027 AGM, (ii) 12 months after approval, or (iii) revocation by shareholders.

Ordinary resolutions • FY 2025 reporting: Shareholders will review the Board’s 2025 work report, the A-share annual report and summary, and audited H-share financial statements. • Profit distribution: A 2025 final-dividend proposal will be tabled; details were not disclosed in the notice. • Auditor appointments: Votes will be held to appoint domestic and overseas financial auditors and a domestic internal-control auditor for 2026, with remuneration to be set by the Board. • Compensation: Remuneration for Directors and Supervisors for 2025 and proposals for 2026 will be considered. • Capital-return policy: A three-year (2026-2028) shareholder dividend return plan is up for approval. • Governance matters: Shareholders will vote on a remuneration-management framework for directors and senior executives.

Board composition Re-election/election of the ninth Board session includes: – Executive Directors: Zhao Da Jun and Xue Yan (both standing for re-election) – Non-executive Directors: Zhong Tao (new) and Yu Xiao Yang (re-election) – Independent Non-executive Directors: Wang Hong Guang, Lam Siu Wing and Xu Pei Long (all re-elections)

Shareholder logistics The H-share register will be closed from 21 May to 28 May 2026, inclusive. Holders of H-shares recorded by 4:30 p.m. on 21 May 2026 are entitled to attend and vote. Proxy forms must reach Computershare Hong Kong Investor Services by 1:30 p.m. on 27 May 2026. All resolutions will be decided by poll.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10